Abdulrafeh Naqash to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Abdulrafeh Naqash has written about Randomized Controlled Trials as Topic.
Connection Strength
0.187
-
Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials. Lancet Oncol. 2024 Jan; 25(1):62-75.
Score: 0.187